Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Pharmacology: Advances and Applications is Scopus-indexed (Q2, CiteScore 4), WoS ESCI, DOAJ. Published by Dove Medical Press Ltd.
Checked against the index lists dated .
ISSN 1179-1438Verify ISSN ↗
Publisher: Dove Medical Press Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 134 / 278 | 51st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q2, CiteScore 4.
Clinical Pharmacology: Advances and Applications is Q2 in Pharmacology (medical) (rank 134 of 278), by CiteScore 2025.
Clinical Pharmacology: Advances and Applications is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4, which places it in quartile Q2 at the 51st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.408, quartile Q3, with an H-index of 39.
The publisher lists an article processing charge of about US$2,320 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical Pharmacology: Advances and Applications is published by Dove Medical Press Ltd. Its ISSN is 1179-1438.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Clinical Pharmacology: Advances and Applications has an h-index of 41 and a 2-year mean of 2.6 citations per paper (OpenAlex). Its Scopus CiteScore is 4, quartile Q2. On 2-year citations it ranks #94 of 271 Scopus journals in Pharmacology (medical).
Clinical Pharmacology: Advances and Applications published 23 papers in 2025; its busiest recent year was 2020 with 29. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2021–2026), authors are most often from United States (27%), China (14%) and Ethiopia (8.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (19.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.